Physician

Mary-Ellen Mick, D.O.

According to 2025 Medicare claims, Mary-Ellen Mick, D.O. (NPI: 1124339924) practices internal medicine in the Blacksburg-Christiansburg-Radford, VA market, with the plurality of this provider's patient population coming from Radford City, VA. This provider's primary affiliated billing organization is CARILION HEALTHCARE CORPORATION (NPI: 1447206370; TIN: 540506332) and primary practice location at 24073-6345. Mick is affiliated with the Doctors Connected (ACO ID: A4949), participating under the MSSP model.

Mick's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 379 traditional Medicare patients, billed 3,904 HCPCS/CPT codes, and received $157,799 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 10,096 prescription claims across 690 beneficiaries totaling $896,983 in drug costs, led by Ozempic (Semaglutide). DME data shows 531 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $93,539 to $157,799. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $340,897 to $896,983. In contrast, DME billing represents a smaller volume and moved from a lower plateau to a higher plateau, from $4,937 to $36,916.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	571	2,357	$93,539
2016	502	2,724	$125,857
2017	566	2,676	$118,934
2018	462	2,447	$103,035
2019	488	2,605	$120,518
2020	831	3,777	$144,348
2021	781	4,936	$238,502
2022	435	3,256	$167,988
2023	403	2,895	$159,343
2024	379	3,904	$157,799

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	556	5,349	$340,897
2016	673	7,138	$376,344
2017	605	9,694	$596,439
2018	525	9,238	$637,609
2019	583	8,442	$811,201
2020	1,048	13,704	$1,368,535
2021	996	14,219	$1,411,015
2022	804	11,179	$1,087,495
2023	702	9,959	$943,782
2024	690	10,096	$896,983

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	74	160	$2,203
2016	72	226	$6,789
2017	77	424	$12,831
2018	61	503	$13,300
2019	78	475	$14,037
2020	120	766	$31,205
2021	150	843	$42,876
2022	86	517	$30,254
2023	77	597	$34,310
2024	46	531	$31,436

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	229	229	$125
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	356	992	$83
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	270	530	$12
83036	Hemoglobin a1c level	174	222	$10
36415	Insertion of needle into vein for collection of blood sample	251	418	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	90	3,940	$126,157
Eliquis	Apixaban	121	5,616	$109,049
Jardiance	Empagliflozin	51	3,450	$63,318
Tresiba Flextouch U-200	Insulin Degludec	25	1,220	$43,571
Xarelto	Rivaroxaban	27	1,920	$35,500

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	37	$15,605
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	15	117	$8,120
E0443	Portable oxygen contents, gaseous, 1 month's supply = 1 unit	N	N/R	39	$1,770
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	31	65	$1,074
J7626	Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg	N	N/R	22	$1,041

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Mary-Ellen Mick, D.O.?

Tedicare shows public-source Medicare data for Mary-Ellen Mick, D.O. (NPI 1124339924), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mary-Ellen Mick, D.O. have ACO affiliation data?

Mary-Ellen Mick, D.O. is shown with ACO affiliation data for Doctors Connected (MSSP, ACO ID A4949).

What billing organization is linked to Mary-Ellen Mick, D.O.?

Mary-Ellen Mick, D.O. is linked to CARILION HEALTHCARE CORPORATION (billing NPI 1447206370) in the available physician profile data.

Does Mary-Ellen Mick, D.O. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.